Abstract
Lipoprotein nanoparticles delivering an inflammation-targeting signalling inhibitor reduce vascular inflammation in atherosclerotic mice.
Cite
CITATION STYLE
APA
Cooke, J. P., & Ferrari, M. (2018, May 1). Inflammation-targeted vascular nanomedicine. Nature Biomedical Engineering. Nature Publishing Group. https://doi.org/10.1038/s41551-018-0241-y
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free